Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
3192 |
|
| Actual shortage: | 255 (8%) | |
| Anticipated shortage: | 1 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 2926 (92%) | |
Discontinuation Reports |
435 |
|
| To be discontinued: | 2 (0%) | |
| Discontinued: | 410 (94%) | |
| Reversed: | 23 (5%) | |
Late reports |
482 (13%) |
|
Overdue reports |
13 (5%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-LAMOTRIGINE | 100MG | TABLET | Resolved | 2017-04-03 | 2017-05-10 | 5204 |
| TEVA-LANSOPRAZOLE | 15MG | CAPSULE (DELAYED RELEASE) | Resolved | 2019-07-02 | 2021-01-28 | 88177 |
| TEVA-LANSOPRAZOLE | 30MG | CAPSULE (DELAYED RELEASE) | Resolved | 2019-07-02 | 2021-01-28 | 88180 |
| TEVA-LANSOPRAZOLE | 30MG | CAPSULE (DELAYED RELEASE) | Resolved | 2019-07-02 | 2021-01-28 | 88183 |
| TEVA-LANSOPRAZOLE | 30MG | CAPSULE (DELAYED RELEASE) | Resolved | 2021-08-27 | 2023-07-05 | 144747 |
| TEVA-LANSOPRAZOLE | 15MG | CAPSULE (DELAYED RELEASE) | Resolved | 2021-09-16 | 2025-04-29 | 145783 |
| TEVA-LANSOPRAZOLE | 15MG | CAPSULE (DELAYED RELEASE) | Resolved | 2023-06-16 | 2023-07-06 | 195036 |
| TEVA-LANSOPRAZOLE | 30MG | CAPSULE (DELAYED RELEASE) | Resolved | 2023-06-19 | 2025-04-25 | 195649 |
| TEVA-LANSOPRAZOLE | 30MG | CAPSULE (DELAYED RELEASE) | Resolved | 2023-06-20 | 2025-04-25 | 195879 |
| TEVA-LATANOPROST | 0.05MG | SOLUTION | Resolved | 2019-06-18 | 2019-08-06 | 86930 |
| TEVA-LATANOPROST | 0.05MG | SOLUTION | Resolved | 2019-09-05 | 2020-07-10 | 93159 |
| TEVA-LATANOPROST | 50MCG | SOLUTION | Resolved | 2024-02-08 | 2024-08-30 | 218963 |
| TEVA-LATANOPROST | 50MCG | SOLUTION | Actual shortage | 2024-05-09 | 2025-12-02 | 227477 |
| TEVA-LEFLUNOMIDE | 20MG | TABLET | Resolved | 2019-07-02 | 2019-08-06 | 88186 |
| TEVA-LEFLUNOMIDE | 10MG | TABLET | Resolved | 2020-01-09 | 2020-03-05 | 102901 |
| TEVA-LEFLUNOMIDE | 20MG | TABLET | Resolved | 2020-01-09 | 2020-03-05 | 102911 |
| TEVA-LEFLUNOMIDE | 20MG | TABLET | Resolved | 2020-04-23 | 2020-05-08 | 113040 |
| TEVA-LEFLUNOMIDE | 20MG | TABLET | Resolved | 2020-06-18 | 2020-07-23 | 118256 |
| TEVA-LEFLUNOMIDE | 20MG | TABLET | Resolved | 2021-01-07 | 2021-01-14 | 131069 |
| TEVA-LEFLUNOMIDE | 20MG | TABLET | Resolved | 2021-01-22 | 2021-04-21 | 132264 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-VALSARTAN | 40MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258501 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255827 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 160MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255830 |
| TEVA-VALSARTAN/HCTZ | 25MG 160MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255833 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256140 |
| TEVA-VALSARTAN/HCTZ | 25MG 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256143 |
| TEVA-VENLAFAXINE XR | 75MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-02-07 | 2020-02-08 | 105537 |
| TEVA-VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-06-11 | 2020-06-11 | 117546 |
| TEVA-VENLAFAXINE XR | 150MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-09-24 | 2020-09-24 | 124899 |
| TEVA-VORICONAZOLE | 200MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256166 |
| TEVA-VORICONAZOLE | 50MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256169 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-09-27 | 2019-10-01 | 94980 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-10-17 | 2019-10-17 | 96695 |
| ZOLEDRONIC ACID FOR INJECTION | 4MG | SOLUTION | Discontinued | 2025-05-28 | 2025-05-28 | 258583 |
| ZOLEDRONIC ACID INJECTION | 5MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14030 |